AIM/HYPOTHESIS: We investigated whether beta cell neoformation occurs in the transplanted pancreas in patients with type 1 diabetes who had received a simultaneous pancreas-kidney transplant (SPK) and later developed recurrence of autoimmunity. METHODS: We examined pancreas transplant biopsies from nine SPK patients with or without recurrent autoimmunity or recurrent diabetes and from 16 non-diabetic organ donors. Tissues were analysed by immunohistochemistry and immunofluorescence. RESULTS: Numerous cytokeratin-19 (CK-19)(+) pancreatic ductal cells stained for insulin in six SPK recipients with recurrent autoimmunity, in five of whom diabetes requiring insulin therapy recurred. These cells also stained for the transcription factor pancreatic-duodenal homeobox-1 (Pdx-1), which is implicated in pancreatic development and beta cell differentiation. The number of insulin(+) ductal cells varied, being highest in the patient with the most severe beta cell loss and lowest in the normoglycaemic patient. In the patient with the most severe beta cell loss, we detected insulin(+)CK-19(+)Pdx-1(+) cells staining for the proliferation-related Ki-67 antigen (Ki-67), indicating proliferation. We were unable to detect Ki-67(+) beta cells within the islets in any SPK patient. Some insulin(+)CK-19(-) ductal cells contained chromogranin A, suggesting further endocrine differentiation. Insulin(+) cells were rarely noted in the pancreas transplant ducts in three SPK patients without islet autoimmunity and in six of 16 non-diabetic organ donors; these insulin(+) cells were never CK-19(+). CONCLUSIONS/ INTERPRETATION: Insulin(+) pancreatic ductal cells, some apparently proliferating, were found in the transplanted pancreas with recurrent islet autoimmunity/diabetes. Replicating beta cells were not detected within islets. The observed changes may represent attempts at tissue remodelling and beta cell regeneration involving ductal cells in the human transplanted pancreas, possibly stimulated by hyperglycaemia and chronic inflammation.
AIM/HYPOTHESIS: We investigated whether beta cell neoformation occurs in the transplanted pancreas in patients with type 1 diabetes who had received a simultaneous pancreas-kidney transplant (SPK) and later developed recurrence of autoimmunity. METHODS: We examined pancreas transplant biopsies from nine SPK patients with or without recurrent autoimmunity or recurrent diabetes and from 16 non-diabetic organ donors. Tissues were analysed by immunohistochemistry and immunofluorescence. RESULTS: Numerous cytokeratin-19 (CK-19)(+) pancreatic ductal cells stained for insulin in six SPK recipients with recurrent autoimmunity, in five of whom diabetes requiring insulin therapy recurred. These cells also stained for the transcription factor pancreatic-duodenal homeobox-1 (Pdx-1), which is implicated in pancreatic development and beta cell differentiation. The number of insulin(+) ductal cells varied, being highest in the patient with the most severe beta cell loss and lowest in the normoglycaemic patient. In the patient with the most severe beta cell loss, we detected insulin(+)CK-19(+)Pdx-1(+) cells staining for the proliferation-related Ki-67 antigen (Ki-67), indicating proliferation. We were unable to detect Ki-67(+) beta cells within the islets in any SPK patient. Some insulin(+)CK-19(-) ductal cells contained chromogranin A, suggesting further endocrine differentiation. Insulin(+) cells were rarely noted in the pancreas transplant ducts in three SPK patients without islet autoimmunity and in six of 16 non-diabetic organ donors; these insulin(+) cells were never CK-19(+). CONCLUSIONS/ INTERPRETATION:Insulin(+) pancreatic ductal cells, some apparently proliferating, were found in the transplanted pancreas with recurrent islet autoimmunity/diabetes. Replicating beta cells were not detected within islets. The observed changes may represent attempts at tissue remodelling and beta cell regeneration involving ductal cells in the human transplanted pancreas, possibly stimulated by hyperglycaemia and chronic inflammation.
Authors: S Tanaka; T Kobayashi; K Nakanishi; M Okubo; T Murase; M Hashimoto; G Watanabe; H Matsushita; Y Endo; H Yoshizaki; T Kosuge; M Sakamoto; K Takeuchi Journal: Diabetes Care Date: 2001-09 Impact factor: 19.112
Authors: Helena Reijonen; Erik J Novak; Sharon Kochik; Anne Heninger; Andrew W Liu; William W Kwok; Gerald T Nepom Journal: Diabetes Date: 2002-05 Impact factor: 9.461
Authors: M Bogdani; V Lefebvre; N Buelens; T Bock; M Pipeleers-Marichal; P In't Veld; D Pipeleers Journal: Diabetologia Date: 2003-05-28 Impact factor: 10.122
Authors: Susan Bonner-Weir; Lili Guo; Wan-Chun Li; Limor Ouziel-Yahalom; Philippe A Lysy; Gordon C Weir; Arun Sharma Journal: Rev Diabet Stud Date: 2012-12-28
Authors: George W Burke; Francesco Vendrame; Antonello Pileggi; Gaetano Ciancio; Helena Reijonen; Alberto Pugliese Journal: Curr Diab Rep Date: 2011-10 Impact factor: 4.810
Authors: Francesco Vendrame; Antonello Pileggi; Elsa Laughlin; Gloria Allende; Ainhoa Martin-Pagola; R Damaris Molano; Stavros Diamantopoulos; Nathan Standifer; Kelly Geubtner; Ben A Falk; Hirohito Ichii; Hidenori Takahashi; Isaac Snowhite; Zhibin Chen; Armando Mendez; Linda Chen; Junichiro Sageshima; Phillip Ruiz; Gaetano Ciancio; Camillo Ricordi; Helena Reijonen; Gerald T Nepom; George W Burke; Alberto Pugliese Journal: Diabetes Date: 2010-01-19 Impact factor: 9.461